SYNAPCELL
epileptic, cognitive, movement
disorders

STOP GUESSING

We have to think outside the box.
For us, the only way to move forward in CNS drug discovery is to “crack” the brain,
by directly measuring its [dys]functions as soon as they appear. That is what we do at SynapCell.

EEG
expertise
EEG measures brain [dys]functions
the most accurate translational drug discovery tool
4-Star
Services
From a drug discovery CRO
focused on CNS disorders
Rodent
models
The link to human disease
Epileptic
Disorders
Are used as translational EEG biomarkers for drug discovery
Cognitive
Disorders
Can be accurately targeted
for drug discovery
Movement
Disorders
Correlate with modifications
to EEG activities

News & Events

28th ECNP Congress

Amsterdam | August 29 - September 1st 2015

ADD Symposium’s 2015

Park city, Utah | 17-20 May 2015

AED Trials XIII - 2015

Miami | 13-15 May 2015

Feedback on Eilat XII

Madrid | August 31 - September 3 2014

Twelfth Eilat Conference on new antiepileptic drugs

Madrid | August 31 – September 3 2014